FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

http://www.wikidata.org/entity/Q35073348

about

FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach Clinicopathological examination of dipeptidase 1 expression in colorectal cancer.High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation.Current and Prospective Protein Biomarkers of Lung Cancer.TBX19 is overexpressed in colorectal cancer and associated with lymph node metastasis.Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms.Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression.

P2860

Q28077347-28645EDC-91C7-4483-9C93-7FFB3C45FDFB Q36359897-210E142B-0BEA-45F5-95B3-27773CDF2B8E Q41127852-8FEE3CB2-1174-407B-9D3B-280CB215F35D Q42117499-E29292D1-3C4F-4C57-9E61-F74418B1F451 Q45417541-92949CC4-6769-496D-AA99-A815606AA413 Q47130839-330973D8-CAD9-49E8-BC9E-9652FA71D13C Q47336772-59B3FCB6-D921-4E0B-A423-BB5089B5E518 Q50053792-A8A19E79-88FD-401B-A714-9524A2B1CEC7 Q54976961-C6225A7B-4505-4BE3-845D-AF5405DECE0E Q55362361-C94C70EF-73D9-48F9-8233-743076495094

P2860

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

http://www.wikidata.org/entity/Q35073348

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

@ast

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

@en

type

label

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

@ast

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

@en

prefLabel

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

@ast

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

@en

P1433

Q35073348-F7225E82-AB00-4828-8CAA-C451EA9867EC

P1476

Q35073348-37C6EEF1-056D-4342-8F67-B4ECC26222EB

P2093

Q35073348-0AC46140-6A24-4CFB-8070-B5215C1214A2

Q35073348-6BEA68AE-B9AE-4CC2-83FB-9287F35EF82E

Q35073348-7531004D-C7DD-4C94-AF84-D5CF37BA4B76

Q35073348-75726966-45A0-4BC5-BC39-EC4E1BADFC23

Q35073348-809B875A-0B26-4AE4-AA3F-689590BE3041

Q35073348-8A4C30D0-8EEC-4B46-8973-EB327F5601E1

Q35073348-9C8FE614-8F45-4C84-9476-FB0B54924E3B

Q35073348-B4EE56BC-4390-464E-8367-1B5CBD031A1F

Q35073348-B59DA27D-212D-47E0-B57A-342D0958F9BD

Q35073348-C83F30D3-E8D3-4005-988B-EA074330AB76

P2860

Q35073348-00E7832B-2B21-490A-A3E1-8A000C6AB353

Q35073348-054524E9-9699-4E08-BBDB-51B527376F03

Q35073348-1309E595-4014-4357-92A3-7A1624493051

Q35073348-14A09F3D-8535-488B-B595-64F80CA9EFEF

Q35073348-1ABDD64A-4CE2-4209-8193-2612C99DA4C0

Q35073348-24883693-763B-44EF-A3E8-A8D78AB73A6E

Q35073348-2A52A038-F32D-4F83-9271-EC3BEBCE2CA0

Q35073348-2C4CB60C-16E2-4F77-A6A0-BB115C2577B6

Q35073348-451814E8-FB5A-4DC2-8FF8-5D18A4E2C108

Q35073348-540D9DE5-F504-465C-BBE4-4A44DBB14045

P304

Q35073348-931203C0-9F0C-4EE8-A25E-86D76085C484

P31

Q35073348-63FA9665-2BA1-4FC4-868B-A95A0BB74834

P356

Q35073348-A97628C7-1158-4A43-822B-4116AA6F2642

P433

Q35073348-B370F8DC-1761-41C6-9770-CDF645E7285A

P478

Q35073348-25C29E1A-E34B-47B1-A5C3-A448A15A272C

P577

Q35073348-7FCDC51B-0B9C-4594-AB93-2A0895679419

P5875

Q35073348-B5EE1142-6EE9-4E09-B224-898391F3AC0C

P698

Q35073348-9E2285C2-BD70-454C-8C83-4840F1C3A46B

P921

Q35073348-371C70F5-928F-467A-9E3D-3993F1F2FDC8

P932

Q35073348-8D375FF2-6E5B-4BB4-B869-35BAB889B316

P356

P1433

International Journal of Oncology

P1476

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

@en

P2093

Emi Ito

http://www.w3.org/2001/XMLSchema#string

Hirosumi Tamura

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Suzuki

http://www.w3.org/2001/XMLSchema#string

Jun Osugi

http://www.w3.org/2001/XMLSchema#string

Jun-Ichi Imai

http://www.w3.org/2001/XMLSchema#string

Junji Ezaki

http://www.w3.org/2001/XMLSchema#string

Mitsukazu Gotoh

http://www.w3.org/2001/XMLSchema#string

Naoyuki Okabe

http://www.w3.org/2001/XMLSchema#string

Reiko Honma

http://www.w3.org/2001/XMLSchema#string

Satoshi Muto

http://www.w3.org/2001/XMLSchema#string

P2860

SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas

Global cancer statistics

FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies

FAM83B mediates EGFR- and RAS-driven oncogenic transformation

Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

P304

999-1006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJO.2015.2817

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270909487

http://www.w3.org/2001/XMLSchema#string

P698

25586059

http://www.w3.org/2001/XMLSchema#string

P921

P932

4324586

http://www.w3.org/2001/XMLSchema#string